Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (24${count})

  • LEAPS, 2011
    Supplement to 'Discovery of mGluR4 Potentiators for Symptoms & Side Effects and Disease-Modifying Treatment of PD'

    Promising Outcomes of Original Grant:
    Activation or potentiation of metabotropic glutamate receptor 4 (mGluR4) is a promising new strategy for both Symptoms & Side Effects and disease-modifying...

  • Research Grant, 2021
    Hidden Sorrows of Covid-19: Impact of Stress on Parkinson’s Disease Progression

    Study Rationale: People living with Parkinson’s disease (PD) are very sensitive to stress, which worsens motor symptoms (such as tremor) and leads to anxiety and depression. Studies in animals suggest...

  • Research Grant, 2020
    Targeting of the Raphe-Cortical Pathway to Reduce Levodopa-Induced Psychosis

    Study Rationale:
    Parkinson’s disease is best known as a movement disorder, yet non-motor symptoms such as anxiety, depression and psychosis afflict over 50 percent of patients and severely impact...

  • Improved Biomarkers and Clinical Outcome Measures, 2019
    International Validation of Two Non-motor Symptom Scales in Parkinson’s Disease

    Study Rationale:
    Non-motor Parkinson’s symptoms can fluctuate with dopaminergic medication effectiveness. Anxiety, sadness, lack of energy and fatigue are common symptoms during the off-medication...

  • Therapeutics Development Initiative, 2011
    Pharmacokinetics and Cognitive Side Effects of the Antidyskinetic Drug Fenobam in MPTP-treated Pre-clinical Models

    Promising Outcomes of Original Grant:
    The goal of our original project was to determine if a prodrug of acamprosate could inhibit levodopa-induced dyskinesias (LIDs) in a pre-clinical model. During...

  • Parkinson’s Disease Therapeutics Pipeline Program, 2024
    Investigation of a Novel Therapeutic Approach for Non-motor Symptoms of Parkinson’s Disease

    Study Rationale:                  

    Parkinson's disease (PD) is characterized by both motor symptoms and non-motor symptoms. While progress has been made in addressing motor symptoms, non-motor...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.